[Early hemostasis after coronary therapeutic interventions by using a collagen plug]

Area of Science:

• Cardiovascular Interventions
• Biomaterials Science
• Vascular Access Management

Context:

• Interventional coronary procedures like PTCA, rotablation, laser angioplasty, and stent implantation carry a high risk of bleeding.
• Systemic anticoagulation (heparin, aspirin, coumadine) and large-caliber catheters exacerbate bleeding risks and prolong recovery.
• Effective hemostasis at the puncture site is crucial for patient safety and reducing healthcare burden.

Purpose:

• To evaluate the efficacy and safety of a bovine collagen plug (VasoSeal) for achieving hemostasis after interventional coronary procedures.
• To assess the impact of the collagen plug on bleeding complications, time to hemostasis, and patient recovery (bed rest duration).
• To compare outcomes with historical data or standard compression methods.

Summary:

• A bovine collagen plug (VasoSeal) was used in 600 patients undergoing interventional coronary procedures.
• The majority of patients (79%) experienced no or minimal bleeding, with reduced bed rest from over 24 hours to 6-12 hours.
• Significant bleeding occurred in 11% of patients, and major complications were rare (10.2%), with most managed conservatively. Rare adverse events included arterial narrowing and embolization.

Impact:

• The VasoSeal collagen plug significantly reduces puncture site bleeding and shortens recovery time, enhancing patient comfort and hospital resource utilization.
• The device demonstrates a favorable safety profile, with most complications being minor and manageable.
• Widespread adoption could improve the standard of care for patients undergoing percutaneous coronary interventions, lowering complication rates and improving patient experience.